11/24
04:30 pm
eton
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
Low
Report
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
11/15
10:33 am
eton
Eton Pharmaceuticals (NASDAQ:ETON) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Eton Pharmaceuticals (NASDAQ:ETON) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/12
04:30 pm
eton
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Medium
Report
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
11/6
07:20 pm
eton
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates [Yahoo! Finance]
11/6
04:40 pm
eton
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/6
04:05 pm
eton
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
Medium
Report
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
10/24
11:09 pm
eton
Eton Pharmaceuticals Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold [Seeking Alpha]
Low
Report
Eton Pharmaceuticals Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold [Seeking Alpha]
10/23
04:30 pm
eton
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Low
Report
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
10/9
07:15 am
eton
Eton Pharmaceuticals (NASDAQ:ETON) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Medium
Report
Eton Pharmaceuticals (NASDAQ:ETON) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
10/3
03:35 pm
eton
Eton Pharmaceuticals (NASDAQ:ETON) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Eton Pharmaceuticals (NASDAQ:ETON) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/22
10:16 am
eton
We Might See A Profit From Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Soon [Yahoo! Finance]
Low
Report
We Might See A Profit From Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Soon [Yahoo! Finance]